In both 2009 and 2012, Tesla, Inc. and its founder and Chief Executive Officer Elon Musk agreed to compensation plans with significant stock option grants that would vest in tranches.
We previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, "Moderna") against BioNTech SE, BioNTech Manufacturing GmbH.
In this episode of "The Trial Lawyer's Handbook" podcast series, litigation attorney Dan Small discusses the real-world challenges of direct examination.
Three cases, all argued this term before the United States Supreme Court and likely to be decided in June, carry major implications for litigation between federal agencies and regulated entities.